Drug Resistance and Epidemiological Success of Modern Mycobacterium tuberculosis Lineages in Western India

Avika Dixit, Yasha Ektefaie, Anju Kagal, Luca Freschi, Rajesh Karyakarte, Rahul Lokhande, Matthias I. Gröschel, Jeffrey A. Tornheim, Nikhil Gupte, Neeta Pradhan, Mandar Paradkar, Sona Deshmukh, Dileep Kadam, Marco Schito, David M. Engelthaler, Amita Gupta, Jonathan Golub, Vidya Mave, Maha FarhatThe Journal of Infectious Diseases 2024 · DOI

Abstract

L2 shows a higher frequency of resistance, and both L2 and L4 demonstrate evidence of higher epidemiological success than L3 or L1 in Pune. Contact tracing around TB cases and heightened surveillance of TB DR in India is a public health priority.
BibTeX
@article{dixit2024drug,
  author = {Avika Dixit and Yasha Ektefaie and Anju Kagal and Luca Freschi and Rajesh Karyakarte and Rahul Lokhande and Matthias I. Gröschel and Jeffrey A. Tornheim and Nikhil Gupte and Neeta Pradhan and Mandar Paradkar and Sona Deshmukh and Dileep Kadam and Marco Schito and David M. Engelthaler and Amita Gupta and Jonathan Golub and Vidya Mave and Maha Farhat},
  title = {{Drug Resistance and Epidemiological Success of Modern <i>Mycobacterium tuberculosis</i> Lineages in Western India}},
  journal = {The Journal of Infectious Diseases},
  year = {2024},
  doi = {10.1093/infdis/jiae240},
}

Loading related content...

Figure